FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Hillary Clinton says migration ‘went too far’ and ‘needs to be fixed in a humane way’

Rubio meets with Zelenskyy ahead of crucial Geneva talks as he says Trump wants solution that ‘ends bloodshed’

AOC’s Latest Word-Salad Answer on Taiwan Puts Even Kamala Harris to Shame

FAA Puts DEI in the Crosshairs, Threatens Any Airline That Doesn’t Hire By Merit

Over 190,000 ‘lethal’ doses of cocaine seized in Valentine’s Day week bust at southern border

‘Cheaters’: Trump Says Voter ID Will Be Required for Midterms Whether Congress Passes SAVE Act or Not

Retired FBI agent urges rapid DNA testing in Guthrie case: ‘You don’t wait for FedEx on Monday morning’

Alexei Navalny’s widow demands ‘accountability’ for Putin after European leaders say husband was poisoned

ICE ramps up deportation push by boosting capacity to 92,600 beds with $38.3B expansion

A $10 Walmart gun holster could help identify suspect in Nancy Guthrie case

Casey Wasserman to sell his talent agency after becoming ‘distraction’ due to Epstein files

Fetterman slams Democrats’ ‘Jim Crow 2.0’ voter ID rhetoric as party unity fractures

ICE officers face criminal probe for alleged ‘untruthful statements’ under oath about Minneapolis shooting

Trump trounces Biden energy records in just months as admin celebrates 1 year of ‘historic gains’: data

Heroic 12-Year-Old Tried to Save Classmates from Trans Mass Shooter: She’s in Critical Condition

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”